EMA Poses Three Questions For the Public Ahead Of Valproate Hearing

 
• By Neena Brizmohun

The European Medicines Agency will be choosing speakers for its public hearing on valproate in September based on how they propose to address three questions. Pharmaceutical companies can apply too.

Politician
Speakers at the EMA’s public hearing on valproate must address three questions • Source: Shutterstock

More from Drug Safety

More from Pink Sheet